The drug, manufactured by the pharmaceutical company Eisai in Tokyo and Biogen in Cambridge, Massachusetts, is given intravenously every other week.
from Articles | Mail Online https://ift.tt/3SCPrbq
from Articles | Mail Online https://ift.tt/3SCPrbq
Comments
Post a Comment